Establishing dosing recommendations for Efavirenz in HIV/TB coinfected children less than three years of age.

Por Dangarembizi, Mutsa Bwakura, Samson, Pearl, Capparelli, Edmund V., Moore, Carolyn Bolton, Jean-Philippe, Patrick, Spector, Stephen A., Chakhtoura, Nahida, Benns, Alex, Zimmer, Bonnie, Purdue, Lynette, Jackson, Chivon, Wallis, Carole, Libous, Jennifer L., Chadwick, Ellen G.
Publicado no J Acquir Immune Defic Syndr (2019)

CYP2B6 Genotype-directed dosing is required for optimal efavirenz exposure in children 3 to 36 months with HIV infection

Por MOORE, Carolyn Bolton, CAPPARELLI, Edmund V., SAMSON, Pearl, BWAKURA-DANGAREMBIZI, Mutsa, JEAN-PHILIPPE, Patrick, WORRELL, Carol, HECKMAN, Barbara, PURDUE, Lynette, SPECTOR, Stephen A., BENNS, Alex, BORKOWSKY, William, LOFTIS, Amy, HAWKINS, Elizabeth, WALLIS, Carole, CHADWICK, Ellen G.
Publicado no AIDS (2017)